Page last updated: 2024-10-31

nefazodone and Dyskinesia, Medication-Induced

nefazodone has been researched along with Dyskinesia, Medication-Induced in 1 studies

nefazodone: may be useful as an opiate adjunct

Research Excerpts

ExcerptRelevanceReference
"Nefazodone is an anti-depressant that interacts with a wealth of pharmacological targets, including some that may exert anti-dyskinetic and anti-psychotic effects in Parkinson's disease (PD), notably serotonin 1A and 2A receptors."1.48Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset. ( Bédard, D; Frouni, I; Gourdon, JC; Hamadjida, A; Huot, P; Kwan, C; Nuara, SG, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamadjida, A1
Nuara, SG1
Bédard, D1
Frouni, I1
Kwan, C1
Gourdon, JC1
Huot, P1

Other Studies

1 other study available for nefazodone and Dyskinesia, Medication-Induced

ArticleYear
Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset.
    Naunyn-Schmiedeberg's archives of pharmacology, 2018, Volume: 391, Issue:12

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Calli

2018